Article
Cordycepin derived from engineered Pichia pastoris inhibits fibrosarcoma HT1080 cells by targeting Akt1 and kinase activity
2025-01-17
Abstract excerpt
Fibrosarcoma cells exhibit low sensitivity to chemotherapy and significant drug resistance, emphasizing the urgent need for effective, low-toxicity therapeutic agents with reliable production methods and novel treatment strategies. Cordycepin (3’-deoxyadenosine) has shown promising therapeutic potential in cancer treatment. In this study, cordycepin was produced using a genetically engineered Pichia pastoris stra...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f0eccc5a-f2a0-552d-8744-8b4f920d4615
- DOI
- 10.22541/au.173710998.89396227/v1
